companydata.dkbiomee ApS: Financial statements 2015
CVR: 29829586
biomee ApS (CVR 29829586) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -32,170,559 and a net result of DKK -32,989,267 compared with DKK -17,231,020 the year before. Equity amounted to DKK -7,134,307.
- Gross Profit
- -32,170,559 kr.
- Profit/Loss
- -32,989,267 kr.
- Equity
- -7,134,307 kr.
- Total Assets
- 7,198,288 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -32.2 mio. | -33 mio. | -7.1 mio. | - |
| 2014 | - | -18.3 mio. | -17.2 mio. | -78.7 mio. | - |
| 2013 | - | -15.5 mio. | -18.6 mio. | -61.4 mio. | - |
| 2012 | - | -11 mio. | -11.8 mio. | -42.8 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
Biomee ApS has published its annual report for 2014. Gross profit came to DKK -18,319,893, and the net result was DKK -17,231,020.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity amounted to DKK 23,772,837.